SCHEMBL4408140

SCHEMBL4408140

CCOC(=O)C[Se]C1(CC)C=CC=CC1C(=O)O

nearest known ligand 0.30

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPID Q08752 1/20 0.30
MGAM O43451 1/20 0.30
GAA P10253 1/20 0.30
SI P14410 1/20 0.30
MGAM2 Q2M2H8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15012548 0.72 TSHR (0.34) MGAMGAASIMGAM2
SCHEMBL808481 0.68 GRM6 (0.30)
SCHEMBL9104953 0.67 GAA (0.33) GAA
SCHEMBL8818307 0.66
SCHEMBL1989127 0.65
SCHEMBL7416135 0.65
SCHEMBL39621 0.65
SCHEMBL4991850 0.63
SCHEMBL6935722 0.63
SCHEMBL18091807 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7635491-B2 Method for administering selenium for treating patients suffering from systemic inflammatory response syndrome (SIRS), and composition for implementing the treatment Forceville, Xavier (FR) 2009-12-22 US disclosed